Cullinan Therapeutics, Inc.

CGEM

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001789972

SEC filings (opens in a new tab)

In the last 90 days, Cullinan Therapeutics, Inc. insiders filed 0 open-market purchases and 3 sales; 183 institutions reported holding it in 13F filings for Q2 2026, worth $1.30B in total; no superinvestor holds it.

Q4 2025 vs. Q3 2025

How the institutions holding Cullinan Therapeutics, Inc. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025 All holders in Q3 2025

13F holders of CGEM: Q3 2025 compared with Q4 2025
Measure	Q3 2025	Of which not filed for Q4 2025	Q4 2025	Change
Holders	145	3	153	+11
Shares	61.1M	253.0K	63.2M	+2.36M (+3.9%)
Value	$362.2M	$1.50M	$653.8M	+$293.2M (+81.3%)

3 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (29)

Institutions that held Cullinan Therapeutics, Inc. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to CGEM in Q4 2025
Institution	Shares	Value	% of portfolio
Boothbay Fund Management, LLC	1,237,043	$12.8M	0.34%
Great Point Partners LLC	634,032	$6.56M	2.13%
Point72 Asset Management, L.P.	360,162	$3.73M	0.01%
Schroder Investment Management Group	343,667	$3.41M	0.00%
Elmind Capital, LP	310,000	$3.21M	0.95%
PFM Health Sciences, LP	227,003	$2.35M	0.24%
Jacobs Levy Equity Management, Inc	73,755	$763.4K	0.00%
ADAR1 Capital Management, LLC	50,000	$517.5K	0.04%
Voleon Capital Management LP	49,663	$514.0K	0.01%
NEOS Investment Management LLC	37,519	$388.3K	0.00%
Tema ETFs LLC	36,964	$382.6K	0.03%
ExodusPoint Capital Management, LP	30,487	$315.5K	0.00%
Gsa Capital Partners LLP	27,303	$283.0K	0.02%
Profund Advisors LLC	23,282	$241.0K	0.01%
AlphaCentric Advisors LLC	19,041	$197.1K	0.20%
Schonfeld Strategic Advisors LLC	16,638	$172.2K	0.00%
Great Lakes Advisors, LLC	12,403	$128.4K	0.00%
Nano Cap New Millennium Growth Fund L P	10,000	$103.5K	0.09%
Quarry LP	9,600	$99.4K	0.02%
Seven Fleet Capital Management LP	3,000	$31.1K	0.02%
Los Angeles Capital Management LLC	1,081	$8.17K	0.00%
Umb Bank N A	685	$7.09K	0.00%
US Bancorp	483	$5.00K	0.00%
Advisor Group Holdings, Inc.	243	$2.52K	0.00%
Fortitude Family Office, LLC	58	$600	0.00%
Larson Financial Group LLC	40	$414	0.00%
Smartleaf Asset Management LLC	26	$258	0.00%
SJS Investment Consulting Inc.	20	$207	0.00%
MAI Capital Management	18	$187	0.00%

Sold out (18)

Institutions that held Cullinan Therapeutics, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.

Institutions that sold out of CGEM in Q4 2025
Institution	Shares, Q3 2025	Value, Q3 2025
Franklin Resources Inc	1,416,036	$8.40M
Tang Capital Management LLC	1,121,138	$6.65M
Voss Capital, LLC	221,473	$1.31M
Ameriprise Financial Inc	56,777	$336.7K
Walleye Capital LLC	56,736	$336.4K
Oxford Asset Management LLP	56,486	$335.0K
Prelude Capital Management, LLC	48,652	$288.5K
Axq Capital, LP	32,669	$193.7K
Caption Management, LLC	28,389	$168.3K
Magnetar Financial LLC	26,263	$155.7K
Graham Capital Management, L.P.	26,234	$155.6K
Quadrature Capital Ltd	13,942	$82.7K
Federation des caisses Desjardins du Quebec	6,000	$35.6K
Wexford Capital LP	5,317	$31.5K
FNY Investment Advisers, LLC	1,365	$8.00K
Parkside Financial Bank & Trust	60	$356
True Wealth Design, LLC	36	$214
Colony Group, LLC	3,498	–

Not filed for Q4 2025 yet (3)

Institutions that held Cullinan Therapeutics, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CGEM in Q3 2025 that haven't filed for Q4 2025
Institution	Shares, Q3 2025	Value, Q3 2025
Cubist Systematic Strategies, LLC	222,318	$1.32M
Corton Capital Inc.	27,117	$160.8K
Point72 (DIFC) Ltd	3,553	$21.1K